---
title: "Oramed amends bylaws to streamline written-consent record date, delivery rules"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291329634.md"
description: "Oramed Pharmaceuticals adopted its Fifth Amended and Restated Bylaws, effective June 25, 2026. Key changes include resetting the record-date framework for stockholder written consents to align with Delaware law when no date is set by the board, removing provisions requiring additional disclosures from stockholders seeking a record date, and mandating that written consents be delivered within 60 days of the first consent received."
datetime: "2026-06-30T20:20:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291329634.md)
  - [en](https://longbridge.com/en/news/291329634.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291329634.md)
---

# Oramed amends bylaws to streamline written-consent record date, delivery rules

-   Oramed adopted Fifth Amended and Restated Bylaws, effective June 25, 2026. \* Changes reset the record-date framework for stockholder action by written consent when the board does not set a date, aligning with Delaware law. \* Bylaws drop a provision that required additional disclosures from stockholders seeking a record date for written-consent actions. \* Written consents must now be delivered within 60 days from the first consent delivered to the company. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oramed Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-073709), on June 30, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [ORMP.US](https://longbridge.com/en/quote/ORMP.US.md)

## Related News & Research

- [Oramed CFO Avraham Gabay sells 73,360 shares for $330,646.76](https://longbridge.com/en/news/291589297.md)
- [Oramed Pharmaceuticals COO & Cbo Sold Shares Worth Over $611K](https://longbridge.com/en/news/291590990.md)
- [Israel "Izzy" Englander increased his position in this pharma stock by 780%. Does he know something Wall Street doesn't?](https://longbridge.com/en/news/293842675.md)
- [AstraZeneca CFO says AI is not expected to lead to job cuts](https://longbridge.com/en/news/293905971.md)
- [Liquidia director Stephen M. Bloch sells 200,000 common shares for $17.87 million](https://longbridge.com/en/news/293795060.md)